OpenEvidence faces rival AI makers and mixed reviews of its clinical accuracy
Overview
OpenEvidence, an ad-funded AI tool that doctors use for clinical questions, faces competition from OpenAI's ChatGPT for healthcare and Anthropic's healthcare tools, according to the Financial Times, as reported by Ars Technica.
The startup is valued at $15 billion.
Evidence on its accuracy is mixed. A Mayo Clinic study found it gave accurate, evidence-based recommendations in all five sampled patient cases. A June Nature paper reported that it underperformed general-purpose models such as Gemini and GPT on clinical benchmarks.
Written by AI from the articles below · updated Oct 21, 12:24 PM ET
Check the sources:
Article timeline
The articles in this story. Times are ET.
- Ars Technica · AINewsOpenEvidence, a $15 billion ad-funded clinical AI startup, faces rivals from OpenAI and Anthropic
AIOpenEvidence, an ad-funded AI startup used by doctors, faces competition from OpenAI's ChatGPT for healthcare and Anthropic's healthcare tools, according to the Financial Times. A Mayo Clinic study found it gave accurate, evidence-based recommendations in all five sampled patient cases, while a June Nature paper found it underperformed general-purpose models such as Gemini and GPT on clinical benchmarks.
Heat Trend
Not enough continuous observations to show a trend yet.